Log in to save to my catalogue

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parame...

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parame...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808688901

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

About this item

Full title

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

Publisher

England: BMJ Publishing Group LTD

Journal title

Gut, 2016-08, Vol.65 (8), p.1359-1368

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

ObjectiveType 2 diabetes is an important risk factor for non-alcoholic fatty liver disease (NAFLD), but current guidelines provide conflicting recommendations on whether diabetic patients should be screened for NAFLD. We therefore studied the strategy of screening diabetic patients by FibroScan.DesignLiver fat and fibrosis were assessed by controll...

Alternative Titles

Full title

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1808688901

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808688901

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2015-309265

How to access this item